Plain-English translation of NCT06442852 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Alzheimer Disease research guide →Researchers are looking for tiny molecules called microRNAs in your blood that may be linked to Alzheimer's disease risk and how quickly it progresses. By comparing blood samples from people diagnosed with Alzheimer's and healthy volunteers, scientists hope to find patterns that could help detect the disease earlier and understand why some people's symptoms get worse faster than others.
Right now, doctors don't have an easy way to predict who will develop Alzheimer's or how severe it will be in each person. Finding reliable blood-based markers could change that, allowing doctors to identify at-risk patients sooner and develop treatments before serious memory loss occurs.
You likely qualify if…
You likely don't qualify if…
If you qualify, you'll visit the research site to have a blood sample drawn — a simple procedure similar to a standard blood test. Healthy volunteers and people with Alzheimer's disease will have their samples analyzed and compared to look for differences in microRNA patterns. The study is actively recruiting 500 participants total.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
China